Philly Builds Bio+ Spring Reception: State of the Life Science Market
Tell a Friend About This EventTell a Friend
Philly Builds Bio+ Spring Reception: State of the Life Science Market

6/1/2023
When: Thursday, June 1st, 2023
4:30pm - 8:00pm
Where: The Post
601 Walnut Street
Philadelphia, Pennsylvania  19106
United States
Contact: info@buildsbio.org


Online registration is closed.
« Go to Upcoming Event List  


SPONSORED BY


JUNE 1, 2023
Philly Builds Bio+ Spring Reception:
State of the Life Science Market
The Post:  601 Walnut Street. Philadelphia, PA 19106

Register Now

LIMITED TO 100 ATTENDEES

After record years in 2020 and 2021, growth of the U.S. life sciences industry has returned to a more normal pace in 2023. Demand for lab/R&D space remains well above pre-pandemic levels. Life sciences employment reached a record high at the start of 2023, although the rate of growth slowed.

The state of the life science capital markets coupled with continued inflation and the uncertainties generated by recent banking failures have all had an impact on the state of the life science market. Nevertheless, the longterm outlook for life sciences is still healthy, marked by a strong focus on health and wellness, new therapies and advancements in technology.

This meeting will examine the state of the market and future prospects, highlighting how companies are managing through a changing and uncertain time.

 

AGENDA

4:30 PM - 5:30 PM:
TOURS OF PHILLY BIOLABS AND IMVAX


5:30 PM - 5:45 PM:
CHECK-IN & NETWORKING


5:45 PM - 6:00 PM:
WELCOME & OVERVIEW OF THE MEETING

Moderators:

Nancy J Kelley

Nancy J Kelley
Nancy J Kelley + Associates
President & CEO

Builds Bio+
Founding Member
and Steering Committee

Mitchel W. Simpler

Mitchel W. Simpler
Jaros Baum & Bolles
Partner Emeritus
Builds Bio+ Founding Member
and Steering Committee



6:00 PM - 6:45 PM:
STATE OF THE LIFE SCIENCE MARKET

Moderator:

Lauren Gilchrist

Lauren Gilchrist
Newmark
Executive VP and Market Leader

Speakers:

Joseph Fetterman
Colliers
Executive Vice President

Ian Anderson
CBRE
Senior Director of Research

Neil Brazitis
Newmark
Senior Managing Director

Joseph Colletti
JLL
Executive Vice President


6:45 PM - 7:30 PM:
THE COMPANY VIEW

Moderator:

Eric Hacherl

Eric Hacherl, PhD
Kyttaro Therapeutics
Chief Operating Officer

Speakers:

Sean Hemingway
IMVAX
Chief Operating Officer

Gwen Binder, PhD
Cabaletta Bio
President,
Science and Technology

Kenneth Locke
Carisma Therapeutics
VP, Manufacturing and Supply Chain

Doug Carr
Century Therapeutics
Senior Vice President and Head of Finance


7:30 PM - 8:00 PM:
NETWORKING

 


For assistance with member pricing/
signing into the portal - email
info@buildsbio.org.